Achalasia: Clinical Trials

7 trials for Achalasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 2 unknown, 1 completed, 1 terminated. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Recruiting 2, Unknown 2, Completed 1, Terminated 1, Withdrawn 1

Follow Achalasia: new trials by email Literature Review of Achalasia trials Research Report on Achalasia

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
VZV in the Enteric Nervous System: Pathogenesis and Consequences
ValACYclovir 1000 MG, Shingrix - Achalasia
Phase 4RecruitingVanderbilt University Medical Center402023-03-272026-10-05
Comprehensive Esophageal Diagnostics Study
Atropine challenge, Esophageal muscle biopsy - Achalasia
Phase 4RecruitingEmory University802021-03-172026-09-16
Post Operative Pain Control of POEM Procedure
Fentanyl, Oxycodone - Achalasia
Phase 4UnknownChen Wannan1962020-01-012019-11-26
Botox or Botox With Esophageal Dilation in Patients With Achalasia
Botulinum toxin type A, Endoscope balloon dilator, Patient reported outcomes - Achalasia
Phase 4CompletedVanderbilt University Medical Center92019-05-132026-08-26
Assessing the Efficacy of Steroid Treatment of Achalasia
Apo-Prednisone Cordorol, Detasone - Prednisone - Achalasia
Phase 4WithdrawnMayo Clinic2013-03-012021-11-17
Personalized Peroral Endoscopic Myotomy for Achalasia
peroral endoscopic myotomy - Achalasia, Postoperative Complications
Phase 4UnknownThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School402012-03-012012-04-04
Comparison of Esophageal and Anorectal Manometry Catheters
Air filled balloon catheter, Solid state catheter - Achalasia, Nutcracker Esophagus
Phase 4TerminatedUniversity of Utah52004-01-012008-01-16

Narrower conditions

Esophageal Achalasia (7)  ·  Deglutition Disorders (1)  ·  Esophageal Motility Disorders (1)  ·  Esophageal Spasm, Diffuse (1)  ·  Fecal Incontinence (1)  ·  Pain, Postoperative (1)  ·  Postoperative Complications (1)  ·  Scleroderma, Diffuse (1)

Broader conditions

Digestive System Diseases (7)  ·  Esophageal Diseases (7)  ·  Gastrointestinal Diseases (7)  ·  Deglutition Disorders (6)  ·  Esophageal Motility Disorders (6)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Connective Tissue Diseases (1)  ·  Intestinal Diseases (1)  ·  Neurologic Manifestations (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Pain (1)  ·  Pharyngeal Diseases (1)  ·  Postoperative Complications (1)  ·  Rectal Diseases (1)

Interventions

Adrenal Cortex Hormones (1)  ·  Botulinum Toxins, Type A (1)  ·  Fentanyl (1)  ·  Oxycodone (1)  ·  Patient Reported Outcome Measures (1)  ·  Prednisone (1)  ·  Valacyclovir (1)

Sponsors

Vanderbilt University Medical Center (2)  ·  Chen Wannan (1)  ·  Emory University (1)  ·  Mayo Clinic (1)  ·  The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)  ·  University of Utah (1)

Countries

United States (4)  ·  China (1)

Top investigators

Anand Jain, MD (1)  ·  Dhyanesh Patel, MD (1)  ·  John C Fang, M.D. (1)  ·  Karthik Ravi, MD (1)  ·  Michael Vaezi, MD (1)  ·  Tingsheng Ling (1)  ·  Wannan Chen, MD (1)

NIH funding

K23DK131317 (1), R03DK145962 (1)